Pfizer: Undervalued Healthcare Leader Poised For Further Recovery Seeking Alpha Pfizer: Undervalued Healthcare Leader Poised For Further Recovery. Pfizer (PFE) 6 hours
Pfizer Inc. (PFE): Strong Q2 2024 Dividend Focus with $5 Billion Returned to Shareholders Insider Monkey 2 days
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever The Motley Fool 5 days
Pfizer says drug for deadly cancer condition that causes weight loss shows positive trial data CNBC 1 week
The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly The Wall Street Journal 2 weeks
Pfizer Inc. (PFE) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) Seeking Alpha 3 weeks
Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market Investor's Business Daily 3 weeks
Pfizer. Inc. (PFE): One of the Best Affordable Stocks Under $40 According to Short Sellers Insider Monkey 3 weeks
Pfizer: Look Beyond COVID-19 And The Patent Cliffs – Robust Long-Term Tailwinds Seeking Alpha 3 weeks
Why IBD 50’s Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged Investor's Business Daily 3 weeks
The forgotten pharma stocks left in the dust by Eli-Lilly could be primed for a comeback CNBC 4 weeks
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 High-Yielding Stocks The Motley Fool 1 month
FDA approves new updated COVID-19 vaccines to target KP.2 variant. Here’s what to know Fast Company 1 month
Looking for $1500 in Safe Passive Income Each Year? Invest This Much in Pfizer. 24/7 Wall St. 1 month
Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its Mark Investor's Business Daily 1 month
Pfizer-BioNTech’s COVID-19-and-flu combination drug meets 1 of 2 trial objectives MarketWatch 1 month